The inheritance pattern marked A in the diagram represents autosomal dominant codominant inheritance characteristic of heterozygous familial hypercholesterolemia (HeFH). The clinical anchor is that heterozygotes have LDL-C in the 200–400 mg/dL range with premature CAD typically manifesting in the 4th–5th decade (as seen in this 42-year-old with STEMI and his brother with MI at 45). Homozygotes have LDL-C >500 mg/dL and present with childhood MI. The pedigree demonstrates vertical transmission over four generations, male-to-male transmission (confirming autosomal, not X-linked), and 50% offspring risk. The patient's 14-year-old son with LDL-C 280 mg/dL exemplifies childhood-onset hyperlipidemia in heterozygous offspring. This pattern is caused by >90% of familial hypercholesterolemia cases due to LDLR mutations on chromosome 19p13.2, resulting in reduced hepatic LDL clearance and lifelong elevated LDL-C. (Harrison's Principles of Internal Medicine, 21st ed., Chapter 405)
Harrison's Principles of Internal Medicine, 21st ed., Chapter 405: Disorders of Lipoprotein Metabolism — Familial Hypercholesterolemia
Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.
Daily MCQs, study tips, and topper strategies on Telegram.
Join on Telegram →